Generate:Biomedicines เตรียมเริ่มการศึกษา Phase 3 ระดับโลกของ GB-0895 แอนติบอดีต้าน TSLP ชนิดออกฤทธิ์ยาวเพื่อรักษาโรคหอบหืดรุนแรง ที่พัฒนาด้วย AI
Generate:Biomedicines to Initiate Global Phase 3 Studies of GB-0895, a Long-Acting Anti-TSLP Antibody for Severe Asthma Engineered with AI
Bybit Announces Humanitarian Aid for Sri Lanka as Cyclone Ditwah Triggers Severe Flooding in Southeast Asia
CooperVision Opens Regional Service Centre in partnership with CEVA Logistics to Accelerate Asia Pacific Growth.
NKKTech Global Accelerates APAC Expansion with Singapore Commercial Office and Strong Presence at Major Technology Events
Fujitsu develops multi-AI agent collaboration technology to optimize supply chains, launches joint trials
The Wisdom Derived from the Great Migration: Hakka Medicine – The Unique “Medical Epic” of the Hakka People
